金河生物
(002688)
| 流通市值：28.24亿 | | | 总市值：29.58亿 |
| 流通股本：7.45亿 | | | 总股本：7.80亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,569,845,460.39 | 1,032,475,783.38 | 527,286,393.92 | 2,122,705,317.42 |
| 营业收入 | 1,569,845,460.39 | 1,032,475,783.38 | 527,286,393.92 | 2,122,705,317.42 |
| 二、营业总成本 | 1,455,359,080.31 | 939,200,547.56 | 492,684,043.93 | 1,984,324,012.05 |
| 营业成本 | 1,081,676,706.64 | 723,917,490.32 | 372,218,045.76 | 1,508,912,604.48 |
| 税金及附加 | 10,266,831.09 | 6,988,467.13 | 3,476,771.92 | 16,198,677.86 |
| 销售费用 | 112,866,494.97 | 71,243,633.8 | 34,812,802.01 | 130,716,598.65 |
| 管理费用 | 179,001,604.2 | 99,631,200.39 | 47,667,687.8 | 238,976,458.35 |
| 研发费用 | 45,876,398.38 | 30,742,494.17 | 15,311,156.03 | 82,284,595.87 |
| 财务费用 | 25,671,045.03 | 6,677,261.75 | 19,197,580.41 | 7,235,076.84 |
| 其中:利息费用 | 42,930,731.88 | 26,733,971.28 | 12,537,501.84 | 36,407,347.84 |
| 其中:利息收入 | 4,229,622.67 | 3,061,580.24 | 1,694,903.59 | 1,899,718 |
| 加:投资收益 | - | - | - | -3,936,663.04 |
| 资产处置收益 | -398,962.04 | -398,962.04 | -398,278.75 | -252,410.31 |
| 资产减值损失(新) | -7,433,962.7 | -5,123,458.73 | 2,778,854.56 | -27,146,554.27 |
| 信用减值损失(新) | -3,721,585.38 | -1,787,011.62 | -1,198,700.51 | -4,671,430.25 |
| 其他收益 | 16,187,868.06 | 12,060,801.97 | 7,593,261.13 | 18,866,473.19 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 119,119,738.02 | 98,026,605.4 | 43,377,486.42 | 121,240,720.69 |
| 加:营业外收入 | 63,301.83 | 45,436.97 | 12,518.02 | 96,253.71 |
| 减:营业外支出 | 396,456.77 | 60,301.64 | 500.96 | 2,492,209.25 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 118,786,583.08 | 98,011,740.73 | 43,389,503.48 | 118,844,765.15 |
| 减:所得税费用 | 4,929,239.99 | 2,338,002.77 | 2,949,879.11 | 804,278.2 |
| 六、净利润 | 113,857,343.09 | 95,673,737.96 | 40,439,624.37 | 118,040,486.95 |
| 持续经营净利润 | 113,857,343.09 | 95,673,737.96 | 40,439,624.37 | 118,040,486.95 |
| 归属于母公司股东的净利润 | 103,065,407.57 | 89,359,336.53 | 36,920,074.2 | 75,543,369.47 |
| 少数股东损益 | 10,791,935.52 | 6,314,401.43 | 3,519,550.17 | 42,497,117.48 |
| (一)基本每股收益 | 0.13 | 0.11 | 0.05 | 0.1 |
| (二)稀释每股收益 | 0.13 | 0.11 | 0.05 | 0.1 |
| 八、其他综合收益 | 11,893,192.77 | 14,224,237.67 | -5,844,363.28 | 35,024,493.08 |
| 归属于母公司股东的其他综合收益 | 10,116,109.22 | 12,099,669.13 | -4,970,884.64 | 29,790,554.41 |
| 九、综合收益总额 | 125,750,535.86 | 109,897,975.63 | 34,595,261.09 | 153,064,980.03 |
| 归属于母公司股东的综合收益总额 | 113,181,516.79 | 101,459,005.66 | 31,949,189.56 | 105,333,923.88 |
| 归属于少数股东的综合收益总额 | 12,569,019.07 | 8,438,969.97 | 2,646,071.53 | 47,731,056.15 |
| 公告日期 | 2023-10-30 | 2023-08-23 | 2023-04-28 | 2023-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |